Can novel computing technologies like “quantum computing” transform drug discovery, or at least be a useful tool that adds value to the overall process? Richard Feynman seemed certain of that in his talk “Simulating physics with computers” some 40 years ago, and recent advances have generated significant hope and hype. In this chapter, we explore the specific features of this new tool and then show some examples where it can be applied, looking at QML (Quantum Machine Learning), and some applications for drug discovery including protein and peptide design – that may add value to our existing toolbox. We also discuss current challenges in quantum computer infrastructure which remains in its infancy (the so-called NISQ era) – and describe the situation as a WTFUQC superposition of waiting and working toward fully useful quantum computers. Overall, we aim to provide the reader with a general understanding of the topic as well as further references.
Can novel computing technologies like “quantum computing” transform drug discovery, or at least be a useful tool that adds value to the overall process? Richard Feynman seemed certain of that in his talk “Simulating physics with computers” some 40 years ago, and recent advances have generated significant hope and hype. In this chapter, we explore the specific features of this new tool and then show some examples where it can be applied, looking at QML (Quantum Machine Learning), and some applications for drug discovery including protein and peptide design – that may add value to our existing toolbox. We also discuss current challenges in quantum computer infrastructure which remains in its infancy (the so-called NISQ era) – and describe the situation as a WTFUQC superposition of waiting and working toward fully useful quantum computers. Overall, we aim to provide the reader with a general understanding of the topic as well as further references.
The drug discovery process necessitates a significant investment of time and resources. Typically, over a decade and billions of dollars are required to bring a single drug to market. However, quantum computing may provide a solution to these challenges. It not only has the potential to streamline drug discovery but also to enhance the quality and accuracy of the results. This chapter explores the innovative amalgamation of quantum computing and pharmaceutical research. Traditional drug discovery methods, due to their time-consuming and costly nature, face numerous obstacles. Quantum computing, armed with its extraordinary computational power, could surmount these hurdles by providing efficient and precise simulations of drug molecules. This could, in turn, expedite the discovery of effective drug candidates. The chapter delves into the fundamentals of quantum computing, its application in drug discovery, and specific techniques relevant to this field. It also presents case studies of successful applications and discusses prospects, taking current limitations into account. A particularly exciting development in this field is quantum machine learning, a fusion of quantum mechanics and machine learning. This synergy could accelerate scientific advances by offering robust predictive modeling for drug discovery. Consequently, this chapter provides an in-depth exploration of a potential future in which quantum technology, artificial intelligence, and robotics are fully integrated. Such integration could revolutionize drug discovery, heralding a new era in health care and reshaping the boundaries of medical science and therapeutic development.
Quantum computing has rapidly advanced in recent years due to substantial development in both hardware and algorithms. These advances are carrying quantum computers closer to their impending commercial utility. Drug discovery is a promising area of application that will find a number of uses for these new machines. As a prominent example, quantum simulation will enable faster and more accurate characterizations of molecular systems than existing quantum chemistry methods. Furthermore, algorithmic developments in quantum machine learning offer interesting alternatives to classical machine learning techniques, which may also be useful for the biochemical efforts involved in early phases of drug discovery. Meanwhile, quantum hardware is scaling up rapidly into a regime where an exact simulation is difficult even using the world’s largest supercomputers. We review how these recent advances can shift the paradigm with which one thinks about drug discovery, focusing on both the promises and caveats associated with each development. In particular, we highlight how hybrid quantum-classical approaches to quantum simulation and quantum machine learning could yield substantial progress using noisy-intermediate scale quantum devices, whereas fault-tolerant, error-corrected quantum computers are still in their development phase.
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.
At the forefront of innovation in drug discovery lies quantum machine learning (QML), poised to revolutionize the field with its unparalleled potential. Through the amalgamation of quantum computing and machine learning principles, QML presents novel solutions to complex computational challenges inherent in pharmaceutical research. The chapter explores the multifaceted applications of QML in drug discovery, including predictive modeling of pharmacokinetic and pharmacodynamic properties, personalized medicine, and precision drug design. Despite facing challenges, such as data quality and algorithm optimization, the future of QML in drug discovery is promising. As researchers continue to explore and refine QML techniques, they pave the way for enhanced therapeutic efficacy, optimized combination therapies, and tailored treatment strategies, ultimately advancing the field of drug discovery into new frontiers.
Quantum computing plays a significant role in simulating molecules and atoms and offers advantages in chemistry over classical computing. The potential of Quantum Machine Learning (QML) can be used in drug discovery, chemical reaction simulations, and Material design for pharmaceuticals. QML leverages quantum computing and advanced machine learning to accelerate the identification of drug candidates, predict molecular interactions, and optimize compounds. In this paper, we present a systematic review of the methods used for molecular property prediction and molecular generation using quantum machine learning. We have included the recent research, perspective, advantages, and challenges that must be addressed to achieve this task. The objective of this research is not only to discuss current strategies and methods used for drug discovery but also to promote interdisciplinary research in the field of quantum computing and chemistry for wellness.
It is widely accepted that quantum computation and the science of quantum computation mechanics are excellent tools for drug design and discovery because of their high precision in estimating numerous relevant parameters. A scientist can use quantum computing to perform hundreds of millions of comparisons of complex molecules at the same time to examine matches between the molecules, and both the positive and negative effects of a new therapeutic approach can be predicted. These approaches make the most significant contribution to the development of drugs in clinical use or clinical trials. These methods emerge and develop in tandem with the experimental approaches used in drug design. Quantum Computational (QC) methods offer a highly precise description of protein–ligand interactions. This method defines nuclei and electron behavior and explains molecular interactions in terms of distribution and motion. Quantum computers have the potential to revolutionize computation by solving previously intractable problems. Quantum computers are extremely fast and efficient. They can perform calculations that would take decades or even millennia on today's supercomputers in a matter of seconds. Experts refer to this fact as quantum superiority over other traditional methods. Second, QCs can also be archetypal complicated structures that will allow researchers to understand the interaction of both small molecules and biologics before the preclinical and clinical stages of drug development. In practice, quantum computational methods will not be able to take over every task performed by classical computational methods—at least not anytime soon. However, in the future, these methods may be combined with traditional computational technologies such as machine learning (ML) and artificial intelligence (AI) to pave a new and groundbreaking path toward the goal of drug discovery and development.